06.01.2023
On May 14, Athenex Inc. filed for Chapter 11 bankruptcy as part of an expedited sales process. The bankruptcy includes the Athenex Pharmaceutical Division, manufacturer of multiple generic pharmaceuticals that are already in short supply. The company plans to continue operations through July 1, after which they anticipate the sale to be final.
MHC is closely monitoring the situation and preparing for any potential pharmaceutical supply chain disruptions.
For more on pharmacy shortages, watch the May 24 Provider Forum with Brad Beaman, PharmD, BCPS, and Cathi Cornelius, PharmD, BCPS.